Cancer Research Annual Meeting 2010  Genetics and Biology of Brain Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vizan, P.
Right arrow Articles by Cascante, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vizan, P.
Right arrow Articles by Cascante, M.
[Cancer Research 65, 5512-5515, July 1, 2005]
© 2005 American Association for Cancer Research


Priority Reports

K-ras Codon-Specific Mutations Produce Distinctive Metabolic Phenotypes in Human Fibroblasts

Pedro Vizan1, Laszlo G. Boros4, Agnes Figueras3, Gabriel Capella3, Ramon Mangues2, Sara Bassilian4, Shu Lim4, Wai-Nang P. Lee4 and Marta Cascante1

1 Department of Biochemistry and Molecular Biology, Faculty of Biology, University of Barcelona; 2 Gastrointestinal Research Laboratory, Saint Pau Hospital; 3 Translational Research Laboratory, IDIBELL-Catalan Institute of Oncology, Barcelona, Spain; and 4 SIDMAP, LLC and Department of Pediatrics, Los Angeles Biomedical Research Institute, Harbor-UCLA Medical Center, Torrance, California

Requests for reprints: Marta Cascante, Department of Biochemistry and Molecular Biology, University of Barcelona, C/Martí i Franqués, 1, Barcelona 08028, Spain. Phone: 34-93-4021593; Fax: 34-39-4021219; E-mail: marta{at}bq.ub.es.

Among K-ras mutations, codon 12 mutations have been identified as those conferring a more aggressive phenotype. This aggressiveness is primarily associated with slow proliferation but greatly increased resistance to apoptosis. Using transfected NIH3T3 fibroblasts with a mutated K-ras minigene either at codon 12 (K12) or at codon 13 (K13), and taking advantage of [1,2-13C2]glucose tracer labeling, we show that codon 12 mutant K-ras (K12)-transformed cells exhibit greatly increased glycolysis with only a slight increase in activity along pathways that produce nucleic acid and lipid synthesis precursors in the oxidative branch of the pentose phosphate pathway and via pyruvate dehydrogenase flux. K13 mutants display a modest increase in anaerobic glycolysis associated with a large increase in oxidative pentose phosphate pathway activity and pyruvate dehydrogenase flux. The distinctive differences in metabolic profiles of K12 and K13 codon mutated cells indicate that a strong correlation exists between the flow of glucose carbons towards either increased anaerobic glycolysis, and resistance to apoptosis (K12), or increased macromolecule synthesis, rapid proliferation, and increased sensitivity to apoptosis.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
A. Yalcin, B. F. Clem, A. Simmons, A. Lane, K. Nelson, A. L. Clem, E. Brock, D. Siow, B. Wattenberg, S. Telang, et al.
Nuclear Targeting of 6-Phosphofructo-2-kinase (PFKFB3) Increases Proliferation via Cyclin-dependent Kinases
J. Biol. Chem., September 4, 2009; 284(36): 24223 - 24232.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
P. Vizan, S. Sanchez-Tena, G. Alcarraz-Vizan, M. Soler, R. Messeguer, M.D. Pujol, W.-N. P. Lee, and M. Cascante
Characterization of the metabolic changes underlying growth factor angiogenic activation: identification of new potential therapeutic targets
Carcinogenesis, June 1, 2009; 30(6): 946 - 952.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. V. Recktenwald, R. Kellner, R. Lichtenfels, and B. Seliger
Altered Detoxification Status and Increased Resistance to Oxidative Stress by K-Ras Transformation
Cancer Res., December 15, 2008; 68(24): 10086 - 10093.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
R. J. Gillies, I. Robey, and R. A. Gatenby
Causes and Consequences of Increased Glucose Metabolism of Cancers
J. Nucl. Med., June 1, 2008; 49(Suppl_2): 24S - 42S.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
B. Clem, S. Telang, A. Clem, A. Yalcin, J. Meier, A. Simmons, M. A. Rasku, S. Arumugam, W. L. Dean, J. Eaton, et al.
Small-molecule inhibition of 6-phosphofructo-2-kinase activity suppresses glycolytic flux and tumor growth
Mol. Cancer Ther., January 1, 2008; 7(1): 110 - 120.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K-ras Codon 12 and 13 Mutation-Induced Metabolic Phenotypes
Cancer Res., September 1, 2005; 65(17): 8057 - 8057.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2005 by the American Association for Cancer Research.